TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GENSUPEN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

GENSUPEN

ST13

US500000079256451

Class

5, 10

Filing

79256451

Registration

5917373

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

07/07/2026

Classification

Registered

Trademark type

Word

Nice classes

5, 10

Filing date

03/15/2019

Registration date

11/26/2019

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/12/2026

Last transaction

07/07/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

09

Owner location

PL

Examiner

CIANCI, RYAN MICHAEL

Law office

M70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

BIOTON S.A.

Representatives

John Alumit ALUMIT IP

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparation, namely, human hormones; hormones for medical purposes; pharmaceutical preparation, namely, insulin; insulin

Class 10

Medical devices, instruments and apparatus for delivery of hormonal medicines; medical devices, instruments and apparatus for delivery of insulin; syringes for medical purposes; injection syringes; subcutaneous syringes

Publications

History of USPTO decisions and trademark events.

25 publications found

C71T

CANCELLED SECTION 71

06/12/2026

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

11/26/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/17/2020

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/10/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

03/18/2020

FIMP

FINAL DISPOSITION PROCESSED

03/18/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/26/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

11/26/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/10/2019

PUBO

PUBLISHED FOR OPPOSITION

09/10/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/21/2019

ALIE

ASSIGNED TO LIE

08/08/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/29/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/24/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/24/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/24/2019

RFNT

REFUSAL PROCESSED BY IB

07/05/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/08/2019

RFRR

REFUSAL PROCESSED BY MPU

06/08/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

05/29/2019

CNRT

NON-FINAL ACTION WRITTEN

05/28/2019

DOCK

ASSIGNED TO EXAMINER

05/24/2019

MAFR

APPLICATION FILING RECEIPT MAILED

04/19/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/15/2019

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

04/11/2019

Continuous trademark protection

Get notified about every new filing that threatens GENSUPEN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.